AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucos⦠read more
Healthcare
Medical Devices
36 years
USD
Exclusive to Premium users
$14.93
Price+0.20%
$0.03
$686.968m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$203.271m
-
1y CAGR-
3y CAGR-
5y CAGR-$4.663m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.10
-
1y CAGR-
3y CAGR-
5y CAGR$112.276m
$205.453m
Assets$93.177m
Liabilities$68.188m
Debt33.2%
10.9x
Debt to EBITDA$5.538m
-
1y CAGR-
3y CAGR-
5y CAGR